Insitro is a biotechnology company that uses machine learning and data analysis to develop new treatments for diseases. The company's platform combines large-scale data generation, machine learning, and high-throughput biology to create predictive models of disease and drug response. Insitro aims to accelerate the drug discovery process and improve the success rate of clinical trials. The company was founded in 2018 by Daphne Koller, and is headquartered in Palo Alto, California.